Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Intracellular Signaling Affects Focal Adhesions

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...

Clot Retraction and Fibrinolysis

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Aspirin and fibrin clot modulation in vascular pharmacology: Fibrinogen acetylation, disease context, and translational uncertainty.

Vascular pharmacology·2026

Same author

Cardiac involvement in Behçet's syndrome: findings from a clinically driven cardiological evaluation.

Rheumatology (Oxford, England)·2026

Same author

Editorial: Iron dysregulation, oxidative stress, and inflammation: mechanisms and therapeutic insights.

Frontiers in molecular biosciences·2026

Same author

Altered global longitudinal strain is a common finding in liver transplant recipients with mild cardiometabolic burden.

Internal and emergency medicine·2026

Same author

Epidemiology changes in systemic lupus erythematosus in Italy: the EASIEST study.

Lupus science & medicine·2026

Same author

Efficacy of Levetiracetam in Patients With Pediatric Epilepsy: A Systematic Review and Meta-Analysis.

Neurology·2026

Search research articles

Related Experiment Video

Updated: Jul 4, 2025

Ferric Chloride-induced Murine Thrombosis Models

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

SIRT1 and thrombosis.

Alessandra Bettiol¹, Maria Letizia Urban¹, Giacomo Emmi¹

¹Department of Experimental and Clinical Medicine, University of Firenze, Firenze, Italy.

Frontiers in Molecular Biosciences

|February 2, 2024

Summary

Sirtuin 1 (SIRT1) is crucial in regulating thrombosis by influencing inflammation and blood clotting. Targeting SIRT1 shows therapeutic potential for preventing thrombosis, as supported by preclinical and clinical evidence.

Keywords:

SIRT1 atherosclerosis oxidative stress sirtuins thrombosis

More Related Videos

Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates

Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates

Published on: February 27, 2016

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis

Published on: June 15, 2011

Related Experiment Videos

Last Updated: Jul 4, 2025

Ferric Chloride-induced Murine Thrombosis Models

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates

Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates

Published on: February 27, 2016

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis

Published on: June 15, 2011

Area of Science:

Biochemistry
Vascular Biology
Pharmacology

Background:

Thrombosis is a leading global cause of death.
Sirtuin 1 (SIRT1) is an NAD+-dependent deacetylase involved in cellular regulation.
SIRT1 modulates key pathways implicated in thrombosis, including endothelial activation, platelet aggregation, and coagulation.

Purpose of the Study:

To review the role of SIRT1 in thrombosis.
To critically assess preclinical and clinical studies investigating SIRT1 as a therapeutic target for thrombosis.

Main Methods:

Literature review of preclinical (in vitro, in vivo) and clinical studies.
Analysis of SIRT1's impact on thrombosis-related pathways.
Evaluation of SIRT1's anti-inflammatory and antioxidant effects.

Main Results:

SIRT1 plays a significant role in regulating thrombosis.
SIRT1 exhibits anti-inflammatory properties, partly through reducing oxidative stress.
Targeting SIRT1 has demonstrated therapeutic potential in preventing thrombosis.

Conclusions:

SIRT1 is a key regulator in thrombosis pathogenesis.
Modulating SIRT1 activity presents a promising therapeutic strategy for thrombosis prevention.
Further research is warranted to fully elucidate SIRT1's clinical applications in managing thrombotic disorders.